Difficulty: Medium
Average Score: 66%
Practice
Your patient with newly diagnosed COPD is receiving a beta 2 agonist via SVN for the first time. Preassessment shows HR 75 bpm with post assessment HR elevated to 132 bpm. The RT should:
Correct answer
C
Rationale
The correct answer is C) Terminate the treatment and notify the physician. In this scenario, the significant increase in heart rate from 75 to 132 bpm post-administration of the beta-2 agonist via SVN indicates a severe adverse reaction to the medication, namely tachycardia. Tachycardia can be a dangerous side effect that can lead to further complications in a patient with COPD. Therefore, stopping the treatment and promptly notifying the physician is crucial to ensure the patient's safety and well-being.
Option A is incorrect because continuing with the same medication via a different route (MDI/spacer) may still lead to the same adverse reaction due to the nature of the medication itself. Option B is incorrect as simply documenting the findings without taking immediate action to address the tachycardia is negligent and puts the patient at risk. Option D is incorrect because switching to a different medication without addressing the tachycardia first could exacerbate the situation and is not the immediate priority.
This scenario provides valuable educational context for healthcare providers to recognize and respond to adverse drug reactions promptly and appropriately. Understanding the potential side effects of medications and knowing when to intervene or seek further guidance from a physician is essential in providing safe and effective patient care in a clinical setting.
Option A is incorrect because continuing with the same medication via a different route (MDI/spacer) may still lead to the same adverse reaction due to the nature of the medication itself. Option B is incorrect as simply documenting the findings without taking immediate action to address the tachycardia is negligent and puts the patient at risk. Option D is incorrect because switching to a different medication without addressing the tachycardia first could exacerbate the situation and is not the immediate priority.
This scenario provides valuable educational context for healthcare providers to recognize and respond to adverse drug reactions promptly and appropriately. Understanding the potential side effects of medications and knowing when to intervene or seek further guidance from a physician is essential in providing safe and effective patient care in a clinical setting.